The impact of switching P2Y12 receptor inhibitor therapy during index hospitalization: a systematic review

被引：0
|
作者：
Jaya Chandrasekhar
Benjamin Hibbert
Michael Froeschl
Derek So
Roxana Mehran
Michel Le May
机构：
[1] University of Ottawa Heart Institute,Division of Cardiology
[2] CAPITAL Research Group,undefined
[3] Icahn School of Medicine at Mount Sinai,undefined
来源：
European Journal of Clinical Pharmacology | 2016年 / 72卷
关键词：
Switching; P2Y; receptor blockers; Acute coronary syndrome; Percutaneous coronary intervention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：83 / 91
页数：8
相关论文
共 50 条
  • [21] P2Y12 inhibitor in acute coronary syndromes
    Wiwanitkit, Viroj
    NATIONAL MEDICAL JOURNAL OF INDIA, 2013, 26 (04): : 249 - 249
  • [22] Selatogrel, a novel P2Y12 inhibitor: a review of the pharmacology and clinical development
    Milluzzo, Rocco P.
    Franchina, Gabriele A.
    Capodanno, Davide
    Angiolillo, Dominick J.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (06) : 537 - 546
  • [23] P2Y12 Inhibitor-Based Monotherapy
    Choudhary, Rahul
    Deora, Surender
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (10) : 1273 - 1274
  • [24] Selatogrel: A Novel Subcutaneous P2Y12 Inhibitor
    Beavers, Craig J.
    Effoe, Samuel. Aaron
    Dobesh, Paul P.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (02) : 161 - 167
  • [25] The effect of P2Y12 inhibitor monotherapy according to bleeding risk: a systematic review and meta-analysis
    Woelders, E. C. I.
    Luijkx, J. P.
    Rodwell, L.
    Winkler, P. J. C.
    Dimitriu-Leen, A. C.
    Smits, P. C.
    Van Royen, N.
    Van'T Hof, A. W. J.
    Damman, P.
    Van Geuns, R. J. M.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1380 - 1380
  • [26] Personalized antiplatelet therapy with P2Y12 receptor inhibitors: benefits and pitfalls
    Winter, Max-Paul
    Kozinski, Marek
    Kubica, Jacek
    Aradi, Daniel
    Siller-Matula, Jolanta M.
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2015, 11 (04): : 259 - 280
  • [27] New Perspectives for Antiplatelet Therapy: The Evolution of P2Y12 Receptor Antagonists
    da Silva, Paula Nogueira
    Barbosa, Maria Leticia de Castro
    REVISTA VIRTUAL DE QUIMICA, 2021, 13 (04) : 999 - 1016
  • [28] Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors
    Kubica, Jacek
    Kubica, Aldona
    Jilma, Bernd
    Adamski, Piotr
    Hobl, Eva-Luise
    Navarese, Eliano Pio
    Siller-Matula, Jolanta Maria
    Dabrowska, Anita
    Fabiszak, Tomasz
    Kozinski, Marek
    Gurbel, Paul Alfred
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 215 : 201 - 208
  • [29] Assessment of Prasugrel Antiplatelet P2Y12 Receptor Therapy in a Clopidogrel Nonresponder
    Ha, Thanh
    Nathan, Sandeep
    Mikrut, Krzysztof
    Miller, Jonathan L.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (03) : 509 - 510
  • [30] P2Y12 receptor constitutive activity as a new target for antiplatelet therapy
    Garcia, C.
    Ribes, A.
    Nauze, M.
    N'guyen, D.
    Martinez, L. O.
    Payrastre, B.
    Senard, J. M.
    Gales, C.
    Pons, V.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 29 - 29
12345